Evidence map›Paper›PMID 41500232›Full record

ArticleBioconjugate chemistry2026

Katie Gristwood, Saimir Luli, Helen J Blair, Kenneth S Rankin, James C Knight

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Bioconjugate chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Katie GristwoodSchool of Natural and Environmental Sciences, Newcastle University, Newcastle upon Tyne NE1 7RU, U.K.ORCID 0009-0002-1289-5262
Saimir LuliPreclinical In Vivo Imaging, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne NE2 4HH, U.K.
Helen J BlairTranslational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne NE1 7RU, U.K.
Kenneth S RankinTranslational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne NE1 7RU, U.K.ORCID 0000-0001-6302-0269
James C KnightSchool of Natural and Environmental Sciences, Newcastle University, Newcastle upon Tyne NE1 7RU, U.K.ORCID 0000-0002-2952-5359

Funding

Wellcome Trust
6 · The paper itself

Abstract

Secondary Cerenkov-induced fluorescence imaging (SCIFI) utilizes blue-weighted Cerenkov luminescence from radioactive decay to excite proximal fluorophores that emit near-infrared light with optimal penetrance through biological tissues and offers potential utility in clinical imaging applications, including guidance of surgical resection. Recently, we developed a self-excitatory immunoSCIFI probe based on an antibody modified with the Cerenkov luminescence generating radioisotope zirconium-89 and a near-infrared boron-dipyrromethene dye (BOD665) and observed an immunoSCIFI signal in

Indexed as

ChondrosarcomaFluorescent DyesOptical ImagingAnimalsCell Line, TumorHumansInfrared RaysMicePorphobilinogenRadioisotopesTissue DistributionZirconiumFluorescent DyesPorphobilinogenRadioisotopesZirconiumZirconium-89

Identifiers

PMID41500232
PMCPMC12828711

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.